| Name | Title | Contact Details |
|---|
SCC was originally founded in 2006, and initially conceived as a direct marketing arm for dealerships. Distinguishing itself by offering premium plans directly to consumers underwritten by A-rated insurers, SCC helps car owners find the right vehicle protection plans within their budget. Our VSC (Vehicle Service Contract) agents walk consumers through the many options available to help navigate the extended auto warranty landscape. Our mission at Secure Car Care is to help you have a better car repair experience by finding the best protection plan for you and your vehicle.
As a locally owned community bank, GRB is dedicated to Growing Rochester. The money deposited with GRB stays here in the form of loans to help local businesses thrive. We help residents buy homes and establish roots in the community. We support local organizations that make Rochester a better place. At GRB, our mission is woven into the fabric of our community. Business Banking For business owners, working with a community bank means having the ability to deal with senior banking professionals who take the time to get to know your company, becoming trusted advisors and strategic partners in helping you sustain business success. A full range of lending and merchant services, coupled with highly personalized service and a unique focus on Rochester delivers a banking relationship that helps local businesses reach their goals. Home Loans and Personal Banking For individuals, choosing a community bank means accessing a wide range of financial products designed to help strengthen your personal financial position. Our full-service mortgage team, GRB Mortgage, provides flexible loan options and local decision making for fast approvals. GRB also has access to special lending and grant programs to help first-time buyers, veterans and more. For your personal finances, our retail banking team provides assistance with CDs, checking/savings accounts, loans and Health Savings Accounts – all designed to help you protect and grow your assets. The GRB Experience At GRB, you will enjoy a level of personalized service simply not found at other banks. We call this "The GRB Experience." We are empowered to think differently and build relationships that support your success. We provide a unique banking experience and add significant value to area businesses and individuals. Thats what it means to be a community bank. Thats what it means to bank at GRB. Member FDIC. Equal Housing Lender. NMLS #417491. GRB is an Equal Opportunity/Affirmative Action Employer. Minority/Female/Sexual Orientation/Gender Identity/Disability/Vet.
Global Synergizers is a social impact consulting firm that collaborates with corporates, social product innovators and social organisations to enable collective impact. Our programs are aligned with UN SDGs and address issues at the local level to create a systemic effect. If you would like to collaborate with us, write to us on info@globalsynergizers.com.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.